These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26456387)

  • 1. Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection.
    Sanchis M; Guarro J; Sutton DA; Fothergill AW; Wiederhold N; Capilla J
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):48-51. PubMed ID: 26456387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal therapies in murine infections by Candida kefyr.
    Sanchis M; Martin-Vicente A; Capilla J; Guarro J
    Mycoses; 2016 Apr; 59(4):253-258. PubMed ID: 26857550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental therapy with azoles against Candida guilliermondii.
    Sanchis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6255-7. PubMed ID: 25049245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
    Majithiya J; Sharp A; Parmar A; Denning DW; Warn PA
    J Antimicrob Chemother; 2009 Jan; 63(1):161-6. PubMed ID: 19008255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata.
    Sanchis M; Capilla J; Castanheira M; Martin-Vicente A; Sutton DA; Fothergill AW; Wiederhold NP; Guarro J
    Int J Antimicrob Agents; 2016 Apr; 47(4):286-8. PubMed ID: 26976780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole and fluconazole susceptibility of Candida isolates.
    Pelletier R; Loranger L; Marcotte H; DE Carolis E
    J Med Microbiol; 2002 Jun; 51(6):479-483. PubMed ID: 12018654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of triazoles in a murine disseminated infection by Candida krusei.
    Mariné M; Pastor FJ; Serena C; Guarro J
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3585-8. PubMed ID: 19470509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.
    Thomson P; Guarro J; Mayayo E; Capilla J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7477-82. PubMed ID: 26392490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
    J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species.
    Sóczó G; Kardos G; McNicholas PM; Balogh E; Gergely L; Varga I; Kelentey B; Majoros L
    J Antimicrob Chemother; 2007 Nov; 60(5):1004-9. PubMed ID: 17875607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives to amphotericin B for Candida rugosa infection.
    Hernandez S; Gonzalez GM; McCarthy DI; Colombo AL; Najvar LK; Bocanegera R; Graybill JR
    J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
    Scorneaux B; Angulo D; Borroto-Esoda K; Ghannoum M; Peel M; Wring S
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole salvage treatment of invasive candidiasis.
    Ostrosky-Zeichner L; Oude Lashof AM; Kullberg BJ; Rex JH
    Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):651-5. PubMed ID: 14564539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-kill methodology.
    Szabo Z; Borbely A; Kardos G; Somogyvari F; Kemény-Beke A; Asztalos L; Rozgonyi F; Majoros L
    Mycoses; 2010 May; 53(3):196-9. PubMed ID: 19761489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.